In an exclusive interview with Investment Reports, Marc Cummings, President and CEO of Life Science Washington, shared details on the state of the life science industry in Washington. He discussed key topics such as clinical diversity, the effects of the pandemic on R&D, and innovation and collaboration in tech and life sciences.
Cummings shared that Washington is focused on creating the next generation of cutting-edge therapies and emphasized the tech convergence within life sciences and how AI is transforming the industry.
“Washington is now in the top 10 life science hubs in the United States, and last year Washington’s early-stage life sciences industry raised over $ 5.1 billion,” said Cummings. “Investors, both nationally and globally, are clearly banking on the sector.”